Viagra, or sildenafil, primarily inhibits phosphodiesterase-5 (PDE5), an enzyme that breaks down cyclic guanosine monophosphate (cGMP). Elevated cGMP levels relax smooth muscle, leading to increased blood flow in the penis, facilitating erection.
Renal implications arise from PDE5’s presence in the kidneys. While the primary effect of Viagra is on vascular smooth muscle, inhibition of renal PDE5 can influence renal blood flow and glomerular filtration rate (GFR). Studies suggest that moderate changes in GFR may occur, particularly in individuals with pre-existing renal impairment.
Patients with severe renal disease should exercise caution. Reduced renal function may lead to increased sildenafil plasma concentrations, potentially increasing the risk of adverse effects such as hypotension and visual disturbances.
Consult a physician before using Viagra, especially if you have kidney problems. They can assess your kidney function and determine the appropriate dosage or an alternative treatment if needed. Regular monitoring of kidney function during Viagra use is advised for individuals with pre-existing renal conditions. Proper dosage adjustment based on renal clearance is crucial.
Specific recommendations must come from your doctor, considering your individual health profile and medication history. Always disclose all medical conditions, including kidney disease, to your healthcare provider before beginning any new medication.
